RHL Group’s Cardinal Health CAH Stock Holding History

RHL Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89.3K	Sell	375 -25	-6%	-$5.2K	0.07%	65
2026 Q1	$84.5K	Buy	+400	New	+$86.1K	0.07%	61

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

RHL Group's CAH Position: Q2 2026 in Review

RHL Group reduced its Cardinal Health (CAH) stake by 6.3% in Q2 2026, selling an estimated $5.2K and leaving 375 shares worth $89.3K. The position accounts for 0.07% of the portfolio, ranked #65.

RHL Group first reported a position in CAH in Q1 2026 and has held it in 2 quarters since. 1,494 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

RHL Group held 375 shares of Cardinal Health worth $89.3K as of Q2 2026.
RHL Group sold 25 Cardinal Health shares in Q2 2026, an estimated $5.2K.
Cardinal Health made up 0.07% of RHL Group's portfolio in Q2 2026, its #65 holding.
RHL Group first reported a position in Cardinal Health in Q1 2026 and has held it in 2 quarters since.
1,494 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on RHL Group's 13F filing for Q2 2026, filed 4 Aug 2026.